Divine Providence: Missing Bleeding Safety Plans - MN

Divine Providence Community Home failed to develop bleeding precautions for the resident, known as R3 in inspection documents, who had been taking Xarelto daily since her admission in August 2025. The 83-year-old woman had moderate cognitive impairment, atrial fibrillation, and a history of heart attack. She required help with bathing, dressing and toileting, and used a walker, wheelchair, and cane for mobility due to physical impairment on one side of her body.

Federal inspectors found the omission during an April 2026 review of care plans for residents receiving anticoagulant therapy.

R3's care plan identified multiple fall risks. She was "weaker and was known to be more fatigued than normal and may not remember to call staff for assistance." The plan noted she "had dementia and was known to be confused" with "muscle weakness and unsteadiness." Her goal was listed as staying "safe while out or moving about, transferring, and to avoid injury."

But nowhere did the care plan mention R3's increased bleeding risk from Xarelto.

"We probably haven't thought of that," registered nurse RN-A told inspectors when asked about the missing bleeding precautions. The nurse agreed that residents on anticoagulants should receive increased monitoring due to their elevated bleeding risk.

The facility's administrator was unaware R3's care plan lacked bleeding precautions and couldn't say whether any residents on anticoagulants had appropriate interventions for their high bleeding risk. She agreed care plans needed proper development.

Xarelto is prescribed to treat and prevent blood clots related to heart and blood vessel conditions. The medication works by stopping specific proteins and enzymes from helping blood clots form, according to patient safety information the inspectors reviewed. This mechanism creates serious bleeding risks.

Patients taking Xarelto bruise more easily and experience prolonged bleeding that can become life-threatening. The manufacturer warns patients to seek immediate medical attention for unexpected bleeding, nosebleeds, unusual gum bleeding, heavy menstrual bleeding, severe bleeding that cannot be controlled, or blood in urine or stool.

Other warning signs include coughing up blood, vomiting blood or material that "looks like coffee grounds," headaches, dizziness, weakness, pain and swelling at wound sites, and abdominal pain that may indicate spleen rupture.

For residents like R3 who are prone to falls, the combination of anticoagulant therapy and fall risk creates particularly dangerous circumstances. Medical research reviewed by inspectors found that falls are "associated with an increased risk of traumatic bleeding events and death" in patients taking blood thinners.

The National Institute for Health Care Excellence recommends head CT scans for people who sustain traumatic brain injuries while on anticoagulant therapy, even when they have no other indications for the scan. A simple fall that might cause minor injury in other patients can trigger serious internal bleeding in someone taking Xarelto.

R3's combination of risk factors made bleeding precautions especially critical. Her dementia meant she might not recognize or report bleeding symptoms. Her mobility limitations and tendency toward falls increased her chances of traumatic injury. Her physical weakness and fatigue, combined with her reluctance to call for help, could delay discovery of bleeding episodes.

Yet staff had no specific protocols to watch for bleeding signs in R3.

The inspection found no facility policy related to anticoagulation monitoring by the survey's completion.

Divine Providence Community Home serves residents requiring various levels of care in Sleepy Eye, a community of about 3,500 people in south-central Minnesota. The facility is located on Third Avenue Northwest.

The violation was classified as causing minimal harm or potential for actual harm, affecting few residents. But the gap in R3's care planning highlighted broader questions about how the facility monitors residents on high-risk medications.

Anticoagulants like Xarelto require careful balance. The medications prevent dangerous blood clots that can cause strokes or heart attacks, particularly in patients with atrial fibrillation like R3. But the same mechanism that prevents clots creates bleeding risks that can prove fatal without proper monitoring.

In nursing home settings, residents often cannot advocate for themselves or recognize warning signs. Staff must be trained to identify bleeding symptoms and respond quickly. Care plans serve as roadmaps for this monitoring, alerting all staff members to specific risks and required interventions.

R3's care plan addressed her fall risk with appropriate detail, recognizing her cognitive impairment, physical limitations, and tendency not to call for help. But it failed to connect these same risk factors to her bleeding vulnerability from Xarelto.

The oversight meant nursing assistants, who provide most direct care in nursing homes, had no guidance about monitoring R3 for bleeding. They weren't alerted to watch for unusual bruising, prolonged bleeding from minor cuts, changes in urine color, or other warning signs that could indicate internal bleeding.

Medical literature emphasizes the importance of individualized bleeding risk assessment for patients on anticoagulants, particularly those with multiple risk factors like R3. Her age, cognitive impairment, fall history, and mobility limitations all increased her bleeding vulnerability beyond the medication's baseline risks.

The facility's registered nurse acknowledged the oversight during the inspection, suggesting staff "probably haven't thought of" the need for bleeding precautions. This response indicated the gap wasn't an isolated documentation error but reflected broader unfamiliarity with anticoagulant monitoring requirements.

The administrator's lack of awareness about bleeding precautions for any residents on anticoagulants suggested the problem might extend beyond R3's case. Without systematic protocols for anticoagulant monitoring, other residents could face similar risks.

R3 continued taking Xarelto daily for her atrial fibrillation while living with dementia, mobility challenges, and fall risks. Her care plan still aimed to keep her safe while moving about and avoid injury. But staff had no written guidance about the bleeding risks that could turn a minor fall into a life-threatening emergency.

Full Inspection Report

The details above represent a summary of key findings. View the complete inspection report for Divine Providence Community Home from 2026-04-15 including all violations, facility responses, and corrective action plans.

Additional Resources

• View all inspection reports for Divine Providence Community Home
• Browse all MN nursing home inspections